Acorah Software Products - Accounts Production 16.3.350 false true 31 August 2023 1 September 2022 false true No description of principal activity 1 September 2023 31 August 2024 31 August 2024 12146293 Dr. Zoi Glarou iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 12146293 2023-08-31 12146293 2024-08-31 12146293 2023-09-01 2024-08-31 12146293 frs-bus:PrivateLimitedCompanyLtd 2023-09-01 2024-08-31 12146293 frs-bus:FilletedAccounts 2023-09-01 2024-08-31 12146293 frs-bus:Micro-entities 2023-09-01 2024-08-31 12146293 frs-bus:AuditExempt-NoAccountantsReport 2023-09-01 2024-08-31 12146293 frs-bus:Director1 2023-09-01 2024-08-31 12146293 2022-08-31 12146293 2023-08-31 12146293 2022-09-01 2023-08-31
Registered number: 12146293
Ikarian Health Ltd
Unaudited Financial Statements
For The Year Ended 31 August 2024
Balance Sheet
Registered number: 12146293
2024 2023
£ £
Fixed assets 1,587 1,984
Current assets 9,236 9,468
NET CURRENT ASSETS 9,236 9,468
TOTAL ASSETS LESS CURRENT LIABILITIES 10,823 11,452
Accruals and deferred income (180 ) -
NET ASSETS 10,643 11,452
CAPITAL AND RESERVES 10,643 11,452

Notes

1. General Information
Ikarian Health Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 12146293 . The registered office is 29 Doulton House 11 Park Street, London, SW6 2FS.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2023: 1)
1 1
For the year ending 31 August 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Dr. Zoi Glarou
Director
22/05/2025